全文获取类型
收费全文 | 495篇 |
免费 | 33篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 3篇 |
妇产科学 | 4篇 |
基础医学 | 21篇 |
口腔科学 | 9篇 |
临床医学 | 40篇 |
内科学 | 121篇 |
皮肤病学 | 3篇 |
神经病学 | 15篇 |
特种医学 | 2篇 |
外科学 | 199篇 |
综合类 | 3篇 |
预防医学 | 66篇 |
眼科学 | 5篇 |
药学 | 25篇 |
肿瘤学 | 8篇 |
出版年
2024年 | 1篇 |
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 31篇 |
2020年 | 12篇 |
2019年 | 16篇 |
2018年 | 38篇 |
2017年 | 20篇 |
2016年 | 13篇 |
2015年 | 13篇 |
2014年 | 31篇 |
2013年 | 42篇 |
2012年 | 55篇 |
2011年 | 52篇 |
2010年 | 28篇 |
2009年 | 20篇 |
2008年 | 35篇 |
2007年 | 37篇 |
2006年 | 12篇 |
2005年 | 28篇 |
2004年 | 17篇 |
2003年 | 7篇 |
2002年 | 6篇 |
2001年 | 3篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1986年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有529条查询结果,搜索用时 15 毫秒
11.
M Soleimani S Barone J Xu GE Shull F Siddiqui K Zahedi H Amlal 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(33):13368-13373
The Na-Cl cotransporter (NCC), which is the target of inhibition by thiazides, is located in close proximity to the chloride-absorbing transporter pendrin in the kidney distal nephron. Single deletion of pendrin or NCC does not cause salt wasting or excessive diuresis under basal conditions, raising the possibility that these transporters are predominantly active during salt depletion or in response to excess aldosterone. We hypothesized that pendrin and NCC compensate for loss of function of the other under basal conditions, thereby masking the role that each plays in salt absorption. To test our hypothesis, we generated pendrin/NCC double knockout (KO) mice by crossing pendrin KO mice with NCC KO mice. Pendrin/NCC double KO mice displayed severe salt wasting and sharp increase in urine output under basal conditions. As a result, animals developed profound volume depletion, renal failure, and metabolic alkalosis without hypokalemia, which were all corrected with salt replacement. We propose that the combined inhibition of pendrin and NCC can provide a strong diuretic regimen without causing hypokalemia for patients with fluid overload, including patients with congestive heart failure, nephrotic syndrome, diuretic resistance, or generalized edema. 相似文献
12.
Miklos Z. Molnar Hirohito Ichii James Lineen Clarence E. Foster rd Zoltan Mathe Jeffrey Schiff S. Joseph Kim Madeleine V. Pahl Alpesh N. Amin Kamyar Kalantar‐Zadeh Csaba P. Kovesdy 《Seminars in dialysis》2013,26(6):667-674
In the last decade, the number of patients starting dialysis after a failed kidney transplant has increased substantially. These patients appear to be different from their transplant‐naïve counterparts, and so may be the timing of dialysis therapy initiation. An increasing number of studies suggest that in transplant‐naïve patients, later dialysis initiation is associated with better outcomes. Very few data are available on timing of dialysis reinitiation in failed transplant recipients, and they suggest that an earlier return to dialysis therapy tended to be associated with worse survival, especially among healthier and younger patients and women. Failed transplant patients may also have unique issues such as continuation of immunosuppression versus withdrawal or the need for remnant allograft nephrectomy with regard to dialysis reinitiation. These patients may have a different predialysis preparation work‐up, worse blood pressure control, higher or lower serum phosphorus levels, lower serum bicarbonate concentration, and worse anemia management. The choice of dialysis modality may also represent an important question for these patients, even though there appears to be no difference in mortality between patients starting peritoneal versus hemodialysis. Finally, failed transplant patients returning to dialysis appear to have a higher mortality rate compared with transplant‐naïve incident dialysis patients, especially in the first several months of dialysis therapy. In this review, we will summarize the available data related to the timing of dialysis initiation and outcomes in failed kidney transplant patients after returning to dialysis. 相似文献
13.
14.
Juan J. Carrero Fridtjof Thomas Kristóf Nagy Fatiu Arogundade Carla M. Avesani Maria Chan Michal Chmielewski Antonio C. Cordeiro Angeles Espinosa-Cuevas Enrico Fiaccadori Fitsum Guebre-Egziabher Rosa K. Hand Adriana M. Hung Talat A. Ikizler Lina R. Johansson Kamyar Kalantar-Zadeh Tilakavati Karupaiah Bengt Lindholm Csaba P. Kovesdy 《Journal of renal nutrition》2018,28(6):380-392
15.
16.
17.
18.
19.
John J. Sim Jiaxiao Shi Csaba P. Kovesdy Kamyar Kalantar-Zadeh Steven J. Jacobsen 《Journal of the American College of Cardiology》2014
Background
Medical data or clinical guidelines have not adequately addressed the ideal blood pressure (BP) treatment targets for survival and renal outcome.Objectives
This study sought to evaluate ranges of treated BP in a large hypertension population and compare risk of mortality and end-stage renal disease (ESRD).Methods
A retrospective cohort study within the Kaiser Permanente Southern California health system was performed from January 1, 2006, to December 31, 2010. Treated hypertensive subjects ≥18 years of age were studied. Cox proportional hazards regression models were used to evaluate the risks (hazard ratios) for mortality and/or ESRD among different BP categories with and without stratification for diabetes mellitus and older age.Results
Among 398,419 treated hypertensive subjects (30% with diabetes mellitus), mortality occurred in 25,182 (6.3%) and ESRD in 4,957 (1.2%). Adjusted hazard ratios (95% confidence intervals [CI]) for composite mortality/ESRD in systolic BP <110, 110 to 119, 120 to 129, 140 to 149, 150 to 159, 160 to 169, and ≥170 compared with 130 to 139 mm Hg were 4.1 (95% CI: 3.8 to 1.3), 1.8 (95% CI: 1.7 to 1.9), 1.1 (95% CI: 1.1 to 1.1), 1.4 (95% CI: 1.4 to 1.5), 2.3 (95% CI: 2.2 to 2.5), 3.3 (95% CI: 3.0 to 3.6), and 4.9 (95% CI: 4.4 to 5.5) respectively. Diastolic BP 60 to 79 mm Hg were associated with the lowest risk. The nadir systolic and diastolic BP for the lowest risk was 137 and 71 mm Hg, respectively. Stratified analyses revealed that the diabetes mellitus population had a similar hazard ratio curve but a lower nadir at 131 and 69 mm Hg but age ≥70 had a higher nadir (140 and 70 mm Hg).Conclusions
Both higher and lower treated BP compared with 130 to 139 mm Hg systolic and 60 to 79 mm Hg diastolic ranges had worsened outcomes. Our study adds to the growing uncertainty about BP treatment targets. 相似文献20.
Taheri Mohammad Noroozi Rezvan Aghaei Kamyar Omrani Mir Davood Ghafouri-Fard Soudeh 《Metabolic brain disease》2020,35(3):497-501
Metabolic Brain Disease - Molybdenum cofactor sulfurase (MOCOS) gene encodes an enzyme which is involved in purine metabolism. Recent experiments have shown down-regulation of MOCOS in adult nasal... 相似文献